GSK stresses need for innovation as herpes vaccine fails to progress
(Alliance News) - GSK PLC on Wednesday said that its vaccine candidate for the herpes simplex virus did not meet a primary efficacy objective in testing, and will not progress to the next phase of studies. Read More